South Pacific

Southern Cross covered about $80,000 of the $105,000 medical costs for Poonia’s treatment, which included chemotherapy and surgery.

Southern Cross Health Insurance is inviting policyholders to upgrade their policies to boost their cover for cancer treatments not funded by Pharmac.

It’s the biggest factor in lagging life expectancy for Māori, who have the worst death rates of any group worldwide.

The savings plan proposal was developed earlier this year by the board's executive management team to reduce its deficit, which had ballooned to about $180m.

An Auckland couple are desperately fundraising for an experimental treatment that may be the only cure for their 7-year-old daughter's cancer.

Liberal MP Craig Kelly said a small handful of bureaucrats in Australia are “ignoring the evidence” and denying Australians access to a medicine which all around the world is “shown to be saving lives”.

The government did not disclose financial terms of the deal, its first vaccine purchase, which will provide enough doses to vaccinate 750,000 people.

Joseph and Julie Moon are abandoning their dream lives in New Zealand, forced to return to America to afford the drug treatment she needs to battle terminal cancer.

With a supportive wife, five daughters and eight grandchildren, Tony Sullivan has something to fight for.

An experimental medication that increases height in children with the most common form of dwarfism has raised hope that it can help them lead easier lives. But some say the condition is not a problem in need of a cure.

The federal government has secured a promising vaccine being developed at Oxford University after brokering a deal with a UK-based drug company.

Australia has now signed a deal with drugmaker AstraZeneca to secure its potential COVID-19 vaccine, joining a growing list of countries lining up for supplies of the drug.

The Health Minister has today announced millions of dollars for Pharmac to secure vital medicine amid fears of a global shortage.

Novartis’s Sandoz division will not profit from 15 generic drugs it is making available to developing countries to treat symptoms of COVID-19 for the pandemic’s duration.

Dr. Paul Griffin discusses the COVID-19 vaccine trial underway in Australia and when results are expected after human testing is completed.